Exploring the association between lifetime prevalence of mental illness and transition from substance use to substance use disorders: Results from the National Epidemiologic Survey of Alcohol and Related Conditions (NESARC)

American Journal on Addictions

Volumn 22, Issue 2, 2013, Pages 93-98

  Lev Ran, Shaul ^a   Imtiaz, Sameer ^a   Rehm, Jürgen ^a,b   Le Foll, Bernard ^a,c  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CANNABIS; COCAINE; NICOTINE; PSYCHEDELIC AGENT;

ADULT; ALCOHOL CONSUMPTION; ALCOHOL USE DISORDER; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; HUMAN; INHALANT ABUSE; LIFESPAN; MAJOR CLINICAL STUDY; MOOD DISORDER; PERSONALITY DISORDER; PREVALENCE; PSYCHOSIS; SUBSTANCE ABUSE; ADOLESCENT; COMPLICATION; DISEASE COURSE; FEMALE; MALE; MENTAL DISORDERS; PSYCHIATRIC DIAGNOSIS; RISK FACTOR; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

ADOLESCENT; ADULT; CROSS-SECTIONAL STUDIES; DIAGNOSIS, DUAL (PSYCHIATRY); DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MENTAL DISORDERS; PREVALENCE; RISK FACTORS; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 84874060372     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1111/j.1521-0391.2013.00304.x     Document Type: Article

References (46)

1. Brooner RK, King VL, Kidorf M, et al. Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Arch Gen Psychiatry. 1997; 54: 71-80.
2. Hien D, Zimberg S, Weisman S, et al. Dual diagnosis subtypes in urban substance abuse and mental health clinics. Psychiatr Serv. 1997; 48: 1058-1063.
3. Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol, other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA. 1990; 264: 2511-2518.
4. Swendsen J, Conway KP, Degenhardt L, et al. Mental disorders as risk factors for substance use, abuse and dependence: Results from the 10-year follow-up of the National Comorbidity Survey. Addiction. 2010; 105: 1117-1128.
5. Kessler RC, Nelson CB, McGonagle KA, et al. The epidemiology of co-occurring addictive and mental disorders: Implications for prevention and service utilization. Am J Orthopsychiatry. 1996; 66: 17-31.
6. Lopez-Quintero C, Perez de los Cobos J, Hasin DS, et al. Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: Results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Drug Alcohol Depend. 2011; 115: 120-130.
7. Wagner FA, Anthony JC., From first drug use to drug dependence; developmental periods of risk for dependence upon marijuana, cocaine, and alcohol. Neuropsychopharmacology. 2002; 26: 479-488.
8. Wagner FA, Anthony JC., Male-female differences in the risk of progression from first use to dependence upon cannabis, cocaine, and alcohol. Drug Alcohol Dependence. 2007; 86: 191-198.
9. Saha TD, Chou SP, Grant BF., Toward an alcohol use disorder continuum using item response theory: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychol Med. 2006; 36: 931-941.
10. Saha TD, Stinson FS, Grant BF., The role of alcohol consumption in future classifications of alcohol use disorders. Drug Alcohol Dependence. 2007; 89: 82-92.
11. Gelhorn H, Hartman C, Sakai J, et al. Toward DSM-V: An item response theory analysis of the diagnostic process for DSM-IV alcohol abuse and dependence in adolescents. J Am Acad Child Adolesc Psychiatry. 2008; 47: 1329-1339.
12. Hartman CA, Gelhorn H, Crowley TJ, et al. Item response theory analysis of DSM-IV cannabis abuse and dependence criteria in adolescents. J Am Acad Child Adolesc Psychiatry. 2008; 47: 165-173.
13. Martin CS, Chung T, Langenbucher JW., How should we revise diagnostic criteria for substance use disorders in the DSM-V ? J Abnorm Psychol. 2008; 117: 561-575.
14. Grant B, Stinson F, Dawson D, et al. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2004; 61: 807-816.
15. Dawson DA, Li TK, Chou SP, et al. Transitions in and out of alcohol use disorders: Their associations with conditional changes in quality of life over a 3-year follow-up interval. Alcohol Alcohol. 2009; 44: 84-92.
16. Grant BF, Moore TC, Kaplan K., Source and Accuracy Statement: Wave 1 National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism; 2003.
17. Huang B, Grant BF, Dawson DA, et al. Race-ethnicity and the prevalence and co-occurrence of Diagnostic and Statistical Manual of Mental Disorders, fourth edition, alcohol and drug use disorders and axis I and II disorders: United States, 2001 to 2002. Compr Psychiatry. 2006; 47: 252-257.
18. Grant BF, Dawson DA, Stinson FS, et al. The alcohol use disorder and associated disabilities interview schedule-IV (AUDADIS-IV): Reliability of alcohol consumption, tobacco use, family history of depression and psychiatric diagnostic modules in a general population sample. Drug Alcohol Dependence. 2003; 71: 7-16.
19. Compton WM, Grant BF, Colliver JD, et al. Prevalence of marijuana use disorders in the United States: 1991-1992 and 2001-2002. JAMA. 2004; 291: 2114-2121.
20. Cottler LB, Grant BF, Blaine J, et al. Concordance of DSM-IV alcohol and drug use disorder criteria and diagnoses as measured by AUDADIS-ADR, CIDI, and SCAN. Drug Alcohol Dependence. 1997; 47: 195-205.
21. Hasin D, Carpenter KM, McCloud S, et al. The alcohol use disorder and associated disabilities interview schedule (AUDADIS): Reliability of alcohol and drug modules in a clinical sample. Drug Alcohol Dependence. 1997; 44: 133-141.
22. Pull CB, Saunders JB, Mavreas V, et al. Concordance between ICD-10 alcohol and drug use disorder criteria and diagnoses as measured by the AUDADIS-ADR, CIDI and SCAN: Results of a cross-national study. Drug Alcohol Dependence. 1997; 47: 207-216.
23. Chatterji S, Saunders JB, Vrasti R, et al. Reliability of the alcohol and drug modules of the alcohol use disorder and associated disabilities interview schedule-alcohol/drug-revised (AUDADIS-ADR): An international comparison. Drug Alcohol Dependence. 1997; 47: 171-185.
24. Vrasti R, Grant BF, Chatterji S, et al. Reliability of the Romanian version of the alcohol module of the WHO alcohol use disorder and associated disabilities: Interview schedule-alcohol/drug-revised. Eur Addict Res. 1998; 4: 144-149.
25. McMillan GP, Timken DS, Lapidus J, et al. Underdiagnosis of comorbid mental illness in repeat DUI offenders mandated to treatment. J Subst Abuse Treat. 2008; 34: 320-325.
26. Supina AL, Patten SB., Self-reported diagnoses of schizophrenia and psychotic disorders may be valuable for monitoring and surveillance. Can J Psychiatry. 2006; 51: 256-259.
27. Software for Survey Data Analysis (SUDAAN) [computer program]. Version 10. Research Triangle Park, NC: Research Triangle Institute; 2004.
28. Morisano D, Bacher I, Audrain-McGovern J, et al. Mechanisms underlying the comorbidity of tobacco use in mental health and addictive disorders. Can J Psychiatry. 2009; 54: 356-367.
29. Dalack GW, Healy DJ, Meador-Woodruff JH., Nicotine dependence in schizophrenia: Clinical phenomena and laboratory findings. Am J Psychiatry. 1998; 155: 1490-1501.
30. Glassman AH., Cigarette smoking: Implications for psychiatric illness. Am J Psychiatry. 1993; 150: 546-553.
31. Hughes JR, Hatsukami DK, Mitchell JE, et al. Prevalence of smoking among psychiatric outpatients. Am J Psychiatry. 1986; 143: 993-997.
32. Sacco KA, Bannon KL, George TP., Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders. J Psychopharmacol. 2004; 18: 457-474.
33. Bondy SJ, Victor JC, Diemert LM., Origin and use of the 100 cigarette criterion in tobacco surveys. Tob Control. 2009; 18: 317-323.
34. Green AI, Noordsy DL, Brunette MF, et al. Substance abuse and schizophrenia: Pharmacotherapeutic intervention. J Subst Abuse Treat. 2008; 34: 61-71.
35. Arndt S, Tyrrell G, Flaum M, et al. Comorbidity of substance abuse and schizophrenia: The role of pre-morbid adjustment. Psychol Med. 1992; 22: 379-388.
36. Westermeyer JJ, Schneekloth TD., Course of substance abuse in patients with and without schizophrenia. Am J Addict. 1999; 8: 55-64.
37. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR). Washington DC: American Psychiatric Association; 2000.
38. Grant BF, Hasin DS, Stinson FS, et al. Prevalence, correlates, and disability of personality disorders in the United States: Results from the national epidemiologic survey on alcohol and related conditions. J Clin Psychiatry. 2004; 65: 948-958.
39. Grant BF, Hasin DS, Stinson FS, et al. Co-occurrence of 12-month mood and anxiety disorders and personality disorders in the US: Results from the national epidemiologic survey on alcohol and related conditions. J Psychiatr Res. 2005; 39: 1-9.
40. Frances A., Categorical and dimensional systems of personality diagnosis: A comparison. Compr Psychiatry. 1982; 23: 516-527.
41. Grant BF, Stinson FS, Dawson DA, et al. Co-occurrence of DSM-IV personality disorders in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Compr Psychiatry. 2005; 46: 1-5.
42. Miller JD, Lynam DR, Widiger TA, et al. Personality disorders as extreme variants of common personality dimensions: Can the Five-Factor Model adequately represent psychopathy ? J Pers. 2001; 69: 253-276.
43. Morey LC, Zanarini MC., Borderline personality: Traits and disorder. J Abnorm Psychol. 2000; 109: 733-737.
44. Wilberg T, Urnes O, Friis S, et al. Borderline and avoidant personality disorders and the five-factor model of personality: A comparison between DSM-IV diagnoses and NEO-PI-R. J Pers Disord. 1999; 13: 226-240.
45. Fazel S, Bains P, Doll H., Substance abuse and dependence in prisoners: A systematic review. Addiction. 2006; 101: 181-191.
46. Lynskey MT, Heath AC, Bucholz KK, et al. Escalation of drug use in early-onset cannabis users vs co-twin controls. JAMA. 2003; 289: 427-433.